\BOOKMARK [1][-]{section.1}{Introduction}{}% 1
\BOOKMARK [2][-]{subsection.1.1}{Problem}{section.1}% 2
\BOOKMARK [2][-]{subsection.1.2}{Solution}{section.1}% 3
\BOOKMARK [1][-]{section.2}{Background}{}% 4
\BOOKMARK [2][-]{subsection.2.1}{Durable Medical Equipment}{section.2}% 5
\BOOKMARK [3][-]{subsubsection.2.1.1}{Importance}{subsection.2.1}% 6
\BOOKMARK [2][-]{subsection.2.2}{Distributed Ledger Technology}{section.2}% 7
\BOOKMARK [3][-]{subsubsection.2.2.1}{Misconceptions}{subsection.2.2}% 8
\BOOKMARK [3][-]{subsubsection.2.2.2}{Importance}{subsection.2.2}% 9
\BOOKMARK [2][-]{subsection.2.3}{Combining DME and DLT}{section.2}% 10
\BOOKMARK [1][-]{section.3}{Architecture}{}% 11
\BOOKMARK [2][-]{subsection.3.1}{Current Model}{section.3}% 12
\BOOKMARK [3][-]{subsubsection.3.1.1}{Electronic Health Records}{subsection.3.1}% 13
\BOOKMARK [3][-]{subsubsection.3.1.2}{Electronic Medical Records}{subsection.3.1}% 14
\BOOKMARK [2][-]{subsection.3.2}{DuraChain Model}{section.3}% 15
\BOOKMARK [2][-]{subsection.3.3}{Users}{section.3}% 16
\BOOKMARK [2][-]{subsection.3.4}{Patient Rooms}{section.3}% 17
\BOOKMARK [2][-]{subsection.3.5}{Facilities and Groups of Patients}{section.3}% 18
\BOOKMARK [2][-]{subsection.3.6}{Electronic Health Events}{section.3}% 19
\BOOKMARK [3][-]{subsubsection.3.6.1}{Unverified Electronic Health Event}{subsection.3.6}% 20
\BOOKMARK [3][-]{subsubsection.3.6.2}{The Noble Eightfold Hash}{subsection.3.6}% 21
\BOOKMARK [3][-]{subsubsection.3.6.3}{Benefits of Event-Based Distribution}{subsection.3.6}% 22
\BOOKMARK [2][-]{subsection.3.7}{Implementation}{section.3}% 23
\BOOKMARK [1][-]{section.4}{UXUI}{}% 24
\BOOKMARK [2][-]{subsection.4.1}{UXUI Overhaul}{section.4}% 25
\BOOKMARK [2][-]{subsection.4.2}{Accessibility}{section.4}% 26
\BOOKMARK [2][-]{subsection.4.3}{Implementation}{section.4}% 27
\BOOKMARK [1][-]{section.5}{Market}{}% 28
\BOOKMARK [2][-]{subsection.5.1}{Target Market}{section.5}% 29
\BOOKMARK [3][-]{subsubsection.5.1.1}{Needs and Wants}{subsection.5.1}% 30
\BOOKMARK [3][-]{subsubsection.5.1.2}{DME Provider Groups}{subsection.5.1}% 31
\BOOKMARK [2][-]{subsection.5.2}{Competition}{section.5}% 32
\BOOKMARK [3][-]{subsubsection.5.2.1}{Brightree}{subsection.5.2}% 33
\BOOKMARK [3][-]{subsubsection.5.2.2}{Lazarus}{subsection.5.2}% 34
\BOOKMARK [3][-]{subsubsection.5.2.3}{Iboss}{subsection.5.2}% 35
\BOOKMARK [3][-]{subsubsection.5.2.4}{Domo}{subsection.5.2}% 36
\BOOKMARK [3][-]{subsubsection.5.2.5}{Health Splash}{subsection.5.2}% 37
\BOOKMARK [1][-]{section.6}{Conclusion}{}% 38
\BOOKMARK [2][-]{subsection.6.1}{Next Steps}{section.6}% 39
\BOOKMARK [2][-]{subsection.6.2}{Future}{section.6}% 40
\BOOKMARK [1][-]{section.7}{Acknowledgements}{}% 41
